Healthcare -
Biotechnology - NASDAQ - GB
$ 1.189
-0.917 %
$ 15 M
Market Cap
-0.48
P/E
AKTX - COST OF REVENUE
Cost of Revenue AKTX - Akari Therapeutics, Plc
4 K
LAST VALUE
-1.54%
2 YEAR CAGR
-35.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR